NCT04725058Active, not recruiting
Obesity Group Visits. A Novel Way to Approach the Obesity Epidemic in an Inner-City Setting
Source: ClinicalTrials.gov · Last updated 15 Apr 2025
Brief summary (registry, in English)
The purpose of this study has two aims: Aim 1: To compare a medical group visit model versus a dietitian-let model (shared composite group visit approach vs individualized dietitian-led approach) to provide obesity care in a real-world diverse inner city population. Aim 2. To use both perivascular fat attenuation and coronary artery calcium (CAC) scores in those receiving composite group intervention vs. dietitian-led intervention to see if lifestyle intervention can reduce plaque progression and improve perivascular fat attenuation.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 1000 (estimated)
- First submitted
- 11 Jan 2021
- Start date
- 3 Feb 2020
- Primary completion date
- 28 Dec 2025
- Lead sponsor
- Charles Drew University of Medicine and Science
- Diseases
- Obesity
- NCT number
- NCT04725058
What you commit to
- Study type: Interventional
- Planned participants: 1000
- From 3 Feb 2020 to the primary completion date, 28 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently on a weight loss medication (orlistat, lorcaserin, and phentermine/topiramate-ER, phenetermine, diethylpropion, phendimetrazine and benzphetamine)
- Currently on metformin or topiramate primarily prescribed for weight loss
Other illness
- Those with mental illness, substance abuse issues as well as other illnesses who are unable to follow directions related to the study or becomes disruptive to the overall group
Lab values
- Patients who have had bariatric surgery less than a year from time of enrollment
- Females \<50 years of age and Males \<40 years of age are not eligible to participate in the sub-study that involves getting a Coronary Artery Calcium (CAC) scan done at the Lundquist Institute.
Age
- Age \<18
Other
- BMI\< 30 kg/m2
- Unwilling to sing consent form
- Currently participating in another obesity treatment program
- Currently pregnant
- Ineligible to receive care at LAC-DHS
Criteria the registry did not label
- Inclusion
- Age ≥ 18
- BMI ≥ 30 kg/m2
- Male, Female, LGBT
- Any ethnicity
- Interested in weight loss and be open to being randomized in either a medical group visit arm or dietitian-led arm (willingly agree to sign consent form)
- Currently within or be eligible to receive care at LAC-DHS and be empaneled to have a primary care provider (PCP) who can adjust their medicines including anti-hypertensive and diabetic medications if needed.
- If had stopped taking weight loss medication (orlistat, lorcaserin, and phentermine/topiramate-ER, phenetermine, diethylpropion, phendimetrazine and benzphetamine) for at least 2 months prior enrollment
- If had stopped taking supplements advertised to increase weight loss at least 3 months prior enrollment
- Females \>50 years of age and Males \>40 years of age meet inclusion criteria to participate in the sub-study that involves getting a Coronary Artery Calcium (CAC) scan done at the Lundquist Institute.
Age in the registry: 18 years to 90 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Charles R. Drew University of Medicine and Science Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.